SCHIZOPHRENIA AND NEURODEVELOPMENT

被引:0
|
作者
HEYMAN, I
MURRAY, RM
机构
[1] INST PSYCHIAT, PSYCHOL MED, DENMARK HILL, LONDON SE5 9RS, ENGLAND
[2] UNIV LONDON KINGS COLL HOSP, LONDON SE5 8RX, ENGLAND
[3] MAUDSLEY HOSP & INST PSYCHIAT, PSYCHIAT, LONDON SE5 8AZ, ENGLAND
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Schizophrenia is characterised by the psychotic symptoms of hallucinations and delusions, accompanied by variable degrees of loss of insight. Whilst there is heterogeneity in the clinical profile, and presumably in the pathogenesis of what is currently called 'schizophrenia', it has become absolutely clear over the past decade that schizophrenic symptoms are consequent upon serious brain dysfunction. This new perspective has laid to rest a variety of 'crazy' theories, including the notion that mental illness was a myth, or that schizophrenia could be caused by faulty child rearing. The use of dopamine-blocking drugs has led to an improvement in symptom control, and diminished the need for prolonged hospital stays. It was hoped that the clear relationship between antipsychotic activity and dopamine blockade would help to elucidate the pathophysiology of schizophrenia, but to date no consistent abnormalities of the dopamine system have been found. Nevertheless, we have learned much about both the aetiology of schizophrenia and the origin of particular symptoms. Much of this has stemmed from increased understanding of the brain abnormalities underlying the disorder.
引用
收藏
页码:143 / 146
页数:4
相关论文
共 50 条
  • [21] Serotonergic functions in a neurodevelopment model of schizophrenia
    Nakagawasai, O.
    Mitazaki, S.
    Onogi, H.
    Watanabe, K.
    Satoh, A.
    Niijima, F.
    Tan-No, K.
    Miyamoto, A.
    Tadano, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 266 - 266
  • [22] Future of Days Past: Neurodevelopment and Schizophrenia
    Weinberger, Daniel R.
    SCHIZOPHRENIA BULLETIN, 2017, 43 (06) : 1164 - 1168
  • [23] Neurodevelopment or neurodegeneration: Review of theories of schizophrenia
    Pino, Oscar
    Guilera, Georgina
    Gomez-Benito, Juana
    Najas-Garcia, Antonia
    Rufian, Silvia
    Rojo, Emilio
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2014, 42 (04): : 185 - 195
  • [24] Rethinking schizophrenia in the context of normal neurodevelopment
    Catts, Vibeke S.
    Fung, Samantha J.
    Long, Leonora E.
    Joshi, Dipesh
    Vercammen, Ans
    Allen, Katherine M.
    Fillman, Stu G.
    Rothmond, Debora A.
    Sinclair, Duncan
    Tiwari, Yash
    Tsai, Shan-Yuan
    Weickert, Thomas W.
    Weickert, Cynthia Shannon
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2013, 7
  • [25] Neurodevelopment in Schizophrenia: The Role of the Wnt Pathways
    Panaccione, Isabella
    Napoletano, Flavia
    Forte, Alberto Maria
    Kotzalidis, Giorgio D.
    Del Casale, Antonio
    Rapinesi, Chiara
    Brugnoli, Chiara
    Serata, Daniele
    Caccia, Federica
    Cuomo, Ilaria
    Ambrosi, Elisa
    Simonetti, Alessio
    Savoja, Valeria
    De Chiara, Lavinia
    Danese, Emanuela
    Manfredi, Giovanni
    Janiri, Delfina
    Motolese, Marta
    Nicoletti, Ferdinando
    Girardi, Paolo
    Sani, Gabriele
    CURRENT NEUROPHARMACOLOGY, 2013, 11 (05) : 535 - 558
  • [26] GENETIC TESTING OF THE NEURODEVELOPMENT HYPOTHESIS OF SCHIZOPHRENIA
    VICENTE, AM
    SASAKI, T
    KING, N
    BARR, CL
    BASSETT, A
    HONER, W
    MACCIARDI, F
    KENNEDY, JL
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 42 - 42
  • [27] Neurodevelopment, GABA System Dysfunction, and Schizophrenia
    Martin J Schmidt
    Karoly Mirnics
    Neuropsychopharmacology, 2015, 40 : 190 - 206
  • [28] The clinical stigmata of aberrant neurodevelopment in schizophrenia
    Buckley, PF
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1998, 186 (02) : 79 - 86
  • [29] Neurodevelopment, GABA System Dysfunction, and Schizophrenia
    Schmidt, Martin J.
    Mirnics, Karoly
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (01) : 190 - 206
  • [30] Neurodevelopment and the Transition from Schizophrenia Prodrome to Schizophrenia: Research Imperatives
    Cannon, Tyrone D.
    BIOLOGICAL PSYCHIATRY, 2008, 64 (09) : 737 - 738